Journal of Psychopharmacology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenwood-Smith, C.
Right arrow Articles by Castle, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenwood-Smith, C.
Right arrow Articles by Castle, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Psychopharmacology, Vol. 17, No. 2, 234-238 (2003)
DOI: 10.1177/0269881103017002014

Serum Clozapine Levels: A Review of Their Clinical Utility

Catherine Greenwood-Smith

Royal Melbourne Hospital, Victoria, Australia.

Dan I. Lubman

Royal Melbourne Hospital, Cognitive Neuropsychiatry Research and Academic Unit, Sunshine Hospital, University of Melbourne, Victoria and Mental Health Research Institute, Victoria, Australia.

David J. Castle

Royal Melbourne Hospital, University of Melbourne, Victoria and Mental Health Research Institute, Victoria, Australia.

Therapeutic drug monitoring (TDM) is frequently utilized in the treatment of psychiatric conditions, but its clinical application concerning the use of clozapine is unclear. We present three case reports of patients taking clozapine, review the relevant literature, and propose guidelines to aid the clinical use of TDM of clozapine. Due to its complex metabolism, there are significant inter- and intra-individual variations in clozapine serum levels, for a given dose. However, the range of serum levels that corresponds with toxicity remains unclear. Although central nervous system side-effects may correlate with serum level, many adverse effects of clozapine appear to be unrelated, including haematological and cardiac events. There are numerous clinically significant interactions between clozapine and other substances, including prescribed medications, nicotine and caffeine. TDM of clozapine may be of clinical value in certain situations, such as poor clinical response; signs of toxicity; onset of seizures; changes in concurrent medication, caffeine or nicotine; liver disease; and suspected non-compliance. The current literature does not support the routine testing of serum clozapine levels in everyday clinical practice.

Key Words: clinical • clozapine • review • serum levels • therapeutic range • toxicity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Psychiatr. Bull.Home page
A. Sparshatt, E. Whiskey, and D. Taylor
Valproate as prophylaxis for clozapine-induced seizures: survey of practice
Psychiatr. Bull., July 1, 2008; 32(7): 262 - 265.
[Abstract] [Full Text] [PDF]

Home page
 PsychosomaticsHome page
J. R. Stevens, O. Freudenreich, and T. A. Stern
Elevated Clozapine Serum Level After Treatment With Amiodarone
Psychosomatics, May 1, 2008; 49(3): 255 - 257.
[Full Text] [PDF]